<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Koch G</dc:creator>
  <dc:creator>Datta AN</dc:creator>
  <dc:creator>Jost K</dc:creator>
  <dc:creator>Schulzke SM</dc:creator>
  <dc:creator>van den Anker J</dc:creator>
  <dc:creator>Pfister M</dc:creator>
  <dc:date>2017</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">OBJECTIVE
To identify dosing strategies that will assure stable caffeine concentrations in preterm neonates despite changing caffeine clearance during the first 8 weeks of life.


METHODS
A 3-step simulation approach was used to compute caffeine doses that would achieve stable caffeine concentrations in the first 8 weeks after birth: (1) a mathematical weight change model was developed based on published weight distribution data; (2) a pharmacokinetic model was developed based on published models that accounts for individual body weight, postnatal, and gestational age on caffeine clearance and volume of distribution; and (3) caffeine concentrations were simulated for different dosing regimens.


RESULTS
A standard dosing regimen of caffeine citrate (using a 20 mg/kg loading dose and 5 mg/kg/day maintenance dose) is associated with a maximal trough caffeine concentration of 15 mg/L after 1 week of treatment. However, trough concentrations subsequently exhibit a clinically relevant decrease because of increasing clearance. Model-based simulations indicate that an adjusted maintenance dose of 6 mg/kg/day in the second week, 7 mg/kg/day in the third to fourth week and 8 mg/kg/day in the fifth to eighth week assures stable caffeine concentrations with a target trough concentration of 15 mg/L.


CONCLUSIONS
To assure stable caffeine concentrations during the first 8 weeks of life, the caffeine citrate maintenance dose needs to be increased by 1 mg/kg every 1-2 weeks. These simple adjustments are expected to maintain exposure to stable caffeine concentrations throughout this important developmental period and might enhance both the short- and long-term beneficial effects of caffeine treatment.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/232201</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jpeds.2017.08.064</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/29173321</dc:relation>
  <dc:source>The Journal of pediatrics. - 2017</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">loading dose</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">maintenance dose</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">maturation</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">pharmacokinetics</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Apnea</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Birth Weight</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Caffeine</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Central Nervous System Stimulants</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Citrates</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Dose-Response Relationship, Drug</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Drug Administration Schedule</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Drug Monitoring</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Infant</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Infant, Newborn</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Infant, Premature</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Infant, Premature, Diseases</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Weight Gain</dc:subject>
  <dc:title xmlns:ns21="xml" ns21:lang="en">Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
